Cost-effectiveness analysis of second intravenous immunoglobulin infusion versus infliximab for treating IVIG-resistant Kawasaki disease patients

Abstract Objective Intravenous immunoglobulin (IVIG) is a known effective treatment to reduce the incidence of coronary artery aneurysms in Kawasaki disease (KD) patients. However, there has been an increase in IVIG-resistant patients and a lack of clinical trial data to determine the best second tr...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Jada M. Johnson, Kit N. Simpson, Annie N. Simpson, Adriana H. Tremoulet, Jane C. Burns
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	BMC 2025-11-01
Rangatū:	Cost Effectiveness and Resource Allocation
Ngā marau:	Pediatrics Persistent fever ICER Comparative effectiveness Coronary artery aneurysm Blood transfusion
Urunga tuihono:	https://doi.org/10.1186/s12962-025-00674-0
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!